000710 贝瑞基因
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.348-12.475-10.861-20.512-10.403
总资产报酬率 ROA (%)-0.877-8.432-7.508-14.372-7.411
投入资产回报率 ROIC (%)-1.049-10.112-8.911-16.689-8.587

边际利润分析
销售毛利率 (%)51.48443.15046.86344.74542.716
营业利润率 (%)-8.419-20.148-15.453-39.147-20.469
息税前利润/营业总收入 (%)-8.020-19.691-15.149-38.117-18.921
净利润/营业总收入 (%)-9.071-21.111-17.453-36.934-18.012

收益指标分析
经营活动净收益/利润总额(%)41.78541.857-3.29311.46618.069
价值变动净收益/利润总额(%)5.2593.3658.60013.63252.214
营业外收支净额/利润总额(%)-0.6501.1712.4270.591-1.317

偿债能力分析
流动比率 (X)2.1031.9562.4371.9302.450
速动比率 (X)1.7851.6782.1071.6302.123
资产负债率 (%)31.81634.15328.07730.88327.288
带息债务/全部投入资本 (%)14.50414.49012.00217.89716.248
股东权益/带息债务 (%)535.830537.624700.282448.824506.053
股东权益/负债合计 (%)206.111189.227250.832220.188263.266
利息保障倍数 (X)-23.325-28.335-22.006-30.192-14.764

营运能力分析
应收账款周转天数 (天)232.108237.763250.439291.137283.014
存货周转天数 (天)156.542126.562133.282130.215106.769